New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases
Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.
Stay updated with breaking news from Ucleic Acid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.
Researchers discuss the use of the highly efficient CRISPR/Cas technologies to identify viral genome sequences for biosafety purposes.
HARBIN, March 20 (Xinhua) -- A mobile, inflatable laboratory for conducting COVID-19 tests was officially put into use on Friday at a sports center in Harbin of
HARBIN, March 20 (Xinhua) -- A mobile, inflatable laboratory for conducting COVID-19 tests was officially put into use on Friday at a sports center in Harbin of
© Provided by Xinhua BEIJING, March 13 (Xinhua) -- China is taking strict and swift measures to stem new COVID-19 infections that have emerged in multi